Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05365_nanopub.RAO7ccNmja40CgUWAhU7pcHlxT6faJRKm5mgriliN8BAA#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05365 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05365 label "BF-200 ALA [drugbank:DB05365]" assertion.
- drugbank:DB05365 seeAlso DB05365 assertion.
- drugbank:DB05365 description "BF-200 ALA is under investigation by Biofrontera which shows positive results from its Phase IIb/III trial. According to Biofrontera, BF-200 ALA was strongly and significantly superior to placebo in the treatment of actinic keratosis." assertion.
- drugbank:DB05365 identifier "drugbank:DB05365" assertion.
- drugbank:DB05365 title "BF-200 ALA" assertion.
- drugbank:DB05365 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05365 drugbank_vocabulary:drugbank-id "DB05365" assertion.
- drugbank:DB05365 bio2rdf_vocabulary:x-identifiers.org DB05365 assertion.
- drugbank:DB05365 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05365" assertion.
- drugbank:DB05365 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05365 bio2rdf_vocabulary:identifier "DB05365" assertion.